This article is mentioned in:

Introduction

Paraquat (PQ) is widely used as a herbicide; however, it is strongly toxic to humans (1). Multiple organ damage is induced by PQ, which is absorbed through the skin, the respiratory tract and the digestive tract (1), and it mainly accumulates in lung cells. The PQ concentration in lung tissue is 6–10-fold higher than that in plasma, and it causes acute pulmonary edema, progressive dyspnea and pulmonary fibrosis (2). PQ poisoning can lead to the production of reactive oxygen species (ROS) and PQ radicals through cyclic reduction/oxidation. Redox cycling is believed to play an essential role in the initiation of lung damage and fibrosis resulting from PQ poisoning (3).

Silent information regulator 2-related enzyme 1 (SIRT1) is a NAD+-dependent protein deacetylase (4) and is involved in various cellular processes, including cell proliferation, apoptosis and inflammation (5). Previous studies have confirmed that SIRT1 plays a significant role in lung injury caused by smoking, bronchial asthma and oxidative stress-related lung diseases (6–8).

Nuclear factor E2-related factor 2 (NRF2) is an important transcription factor, which regulates genes associated with the scavenging of oxygen free radicals, and is regarded as an effective target for antioxidant therapy (9,10). Under conditions of oxidative stress, NRF2 translocates to the nucleus, and then induces the gene expression of downstream detoxification enzymes and antioxidant enzymes, such as superoxide dismutase (SOD) and heme oxygenase-1 (HO-1), in order to produce an antioxidant effect (11–13). Previous studies have revealed that SIRT1 promotes the activity of NRF2 and upregulates the expression of NRF2 downstream genes, such as SOD (14,15), and that the knockdown of SIRT1 results in the downregulation of NRF2 expression (16). In our previous study, we confirmed that NRF2 is activated and plays a role in protecting A549 lung cells against oxidative damage following exposure to PQ (17). However, the association between SIRT1 and NRF2, as well as their effects on PQ-induced oxidative stress remain to be elucidated.

Therefore, in the present study, we aimed to determine whether the SIRT1/NRF2/ARE signaling pathway plays an important role in lung injury induced by PQ. For this purpose, mouse type II alveolar epithelial cells (AECs-II) were exposed to various concentrations of PQ and the effects of PQ on the levels of antioxidant enzymes were determined. In addition, to examine the association between SIRT1 and NRF2, SIRT1 expression was either induced or silenced by transfection of the cells with a SIRT1 overexpression vector or shRNA targeting SIRT1, respectively.

Materials and methods

Animals and reagents

ICR mice (n=20, weighing 18–30 g) of clean grade were provided by the Animal Experimental Center of Wenzhou Medical University (Wenzhou, China). All experimental procedures involving animals were pre-approved in accordance with the Institutional Animal Care and Use Committee guidelines of Wenzhou Medical University. PQ used in this study was purchased from Sigma-Aldrich (St. Louis, MO, USA) and compounded into a liquid of corresponding concentrations. The antibodies, including anti-SIRT1 (#3931), anti-NRF2 (#12721), anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH; #5174) and anti-acetyl lysine (#9441) antibodies were obtained from Cell Signaling Technology (Danvers, MA, USA).

Isolation and culture of mouse AECs-II

The mice were sacrificed by cervical dislocation, and both lungs were quickly removed and placed into 75% ethanol for 5 min. Subsequently, both lungs were moved to a superclean bench and residual tracheal tissue and connective tissue were cleared to the maximum extent possible. Finally, the cleared lung tissues were placed in sterile pre-cold PBS and washed 2 to 3 times. The lung tissues were washed twice in phosphate-buffered saline (PBS) and cut into small sections (approximately 1 mm3) and then digested with 0.25% trypsinase (Gibco, Carlsbad, CA, USA) under gentle agitation at 37°C. After 5 min, digestion was terminated using RPMI-1640 medium with 10% fetal calf serum (both from Gibco, Carlsbad, CA, USA). The above process was repeated once. Subsequently, 0.5% collagenase type I (Sigma-Aldrich) was added at 37°C for 15 min, after which the tissues were centrifuged at 1,000 × g for 5 min and washed twice with RPMI-1640 medium containing 10% fetal calf serum. The cells were then transferred to a 25 cm2 culture flask and cultured in a CO2 incubator (Thermo Fisher Scientific, Waltham, MA, USA) at 37°C.

Transfection and transfection efficiency analysis

For the upregulation or silencing of SIRT1, lentiviral particles to induce the overexpression of SIRT1 and shRNA specific to SIRT1 to silence SIRT1 were synthesized by Shanghai GeneChem Co., Ltd. (Shanghai, China). A lentiviral overexpression vector (LV-SIRT1) and shRNA targeting SIRT1 (shRNA-SIRT1) were used to induce the overexpression of the silencing of SIRT1, respectively. The shRNA-SIRT1 sequence was 5′-GAUGAAGUUGACCUCCUCATT-3′. The cells were seeded in 6-well plates until they grew to approximately 80% coverage, and solutions of the viral particles equal to a multiplicity of infection (MOI) of 80 were then pre-mixed with RPMI-1640 medium and added to the 6-well plates. After 12 h, the medium was replaced with fresh medium. After a further 48 h, the cells were observed under a fluorescence microscope (Olympus CKX41SF; Olympus Corp., Tokyo, Japan), in order to determine the percentage of cells synthesizing green fluorescent protein (GFP). The ratio of the number of cells that emit green fluorescence to the same field of view is the transfection efficiency. We then detected the protein expression of SIRT1 in the transfected mouse AECs-II by western blot analysis.

Exposure of cells to PQ

The AECs-II were either exposed to various concentrations of PQ (0, 200, 400, 800 and 1000 μM) for 24 h or to 800 μM PQ for various periods of time (6, 12, 24 and 48 h). The control cells were untreated cells.

Western blot analysis

After harvesting, the mouse AECs-II were lysed on ice using lysis buffer (Beyotime Biotechnology, Jiangsu, China) for 30 min. Subsequently, the cell lysates were centrifuged at 16,000 × g for 15 min at 4°C. The supernatants were collected and the protein concentration was detected using the bicinchoninic acid (BCA) method. Equal amounts of protein (40 μg/lane) were loaded onto a polyacrymide gel and run at 80 V for 1 h, followed by a 120 V run for 30 min, and then transferred to polyvinylidene fluoride (PVDF) membranes (0.45 μm; Millipore, Billerica, MA, USA) by electroblotting. After blocking with 5% skimmed powdered milk for 2 h, the membranes were correspondingly incubated with anti-SIRT1 (1:1,000), anti-NRF2 (1:1,000) or anti-GAPDH (1:5,000) antibodies overnight at 4°C. The membranes were then washed in Tris-buffered saline-Tween-20 (TBST) 3 times for 10 min each and further incubated with horseradish peroxidase (HRP)-conjugated goat anti-rabbit secondary antibodies (Biogot Technology, Co., Ltd., Shanghai, China) for 2 h at room temperature and detected using an ECL detection system (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA).

Determination of SOD and catalase (CAT) activities, as well as glutathione (GSH) and malondialdehyde (MDA) levels

Following exposure to PQ, either supernatant or cell samples were collected. The SOD and CAT activities were detected according to the manufacturer's instructions (provided with the SOD and CAT assay kits; Jiancheng Bioengineering Institute, Nanjing, China). We also measured the MDA and GSH levels following the instructions provided by the manufacturer (Jiancheng Bioengineering Institute). The samples were analyzed using a spectrophotometer. The SOD and CAT activities were expressed in U/mgprot. The GSH levels were expressed in μmol/gprot and the MDA levels were expressed in nmol/mgprot.

Determination of HO-1 activity by ELISA

The cell supernatants were harvested following exposure of the cells to PQ. HO-1 activity was measured using commercially available enzyme-linked immunosorbent assay (ELISA) kits (Westang Biotechnology, Shanghai, China). ELISA was performed strictly according to the manufacturer's instructions. The samples were analyzed using a spectrophotometer. HO-1 activity was expressed in μg/gprot.

Analysis of cell apoptosis

The cell apoptotic rate was detected using a FACScan flow cytometer (Becton-Dickinson, Franklin Lakes, NJ, USA) with an Annexin V-FITC/propidium iodide (PI) apoptosis detection kit (Nanjing Keygen Biotechnology Co. Ltd., Nanjing, China). Following exposure to PQ, the cells were harvested, washed with ice-cold PBS and then re-suspended in 500 μl binding buffer at a concentration of 1×106 cells/ml. Subsequently, the cells were stained with 5 μl of Annexin V-FITC and 5 μl of PI, followed by incubation for 15 min at room temperature in the dark. Finally, apoptosis was assessed by flow cytometry.

Analysis of protein stability

The cells were seeded in 6-well plates and exposed to 800 μM PQ for 24 h. Subsequently, the culture solution was changed to cycloheximide solution (CHX Sigma-Aldrich) at a concentration of 100 g/ml and treated for 0, 6, 12 and 24 h. The treated cells were collected and processed for western blot analysis following the removal of cycloheximide.

Detection of acetylated NRF2 expression in cells

After harvesting, the whole cell lysates were prepared using non-denaturing lysis buffer (Thermo Fisher Scientific) on ice and immunoprecipitation was performed with the whole cell lysates. Briefly, the lysates were incubated with 1 μg each of either normal rabbit IgG (Cell Signaling Technology) or anti-NRF2 at 4°C with gentle rotation overnight and collected by incubating with Protein A/G Plus Agarose (Thermo Fisher Scientific). The agarose beads were washed and then boiled for 10 min with 1X SDS loading buffer followed by centrifugation at 1,000 × g for 1 min. The immunocomplexes were then detected by western blot analysis using anti-acetyl-lysine antibody (#9441; Cell Signaling Technology).

Statistical analysis

All data are presented as the means ± SD and were analyzed using SPSS 19.0 software (SPSS Inc., Chicago, IL, USA). GraphPad Prism 6 (GraphPad Software Inc., La Jolla, CA, USA) was used to prepare the figures. The comparisons between groups were analyzed using one-way ANOVA. A p-value <0.05 was considered to indicate a statistically significant difference.

Results

Transfection efficiency analysis

As shown in Fig. 1A, the cells in the negative control group cells did not express green fluorescence. Under the condition of a multiplicity of infection (MOI) of 20, the transfection efficiency of the lentivirus in the mouse AECs-II is very low. When the MOI was increased to 80, the transfection efficiency of the lentivirus in the mouse AECs-II increased by >80%. Thus, in all the experiments, the lentivirus was transfected at an MOI of 80. As shown in Fig. 1B, compared with the control group, SIRT1 protein expression in the shRNA-SIRT1 group decreased significantly, while that in the LV-SIRT1 group significantly increased (all p<0.05).

Figure 1 Transfection efficiency analysis. Mouse AECs-II were transfected with a lentiviral overexpression vector (LV-SIRT1) or lentiviral vector carrying shRNA targeting SIRT1 (shRNA-SIRT1). (A) After 72 h, the cells were observed under a fluorescence microscope. (B) The protein expression of SIRT1 was measured by western blot analysis. The values were expressed as the means ± SD (n=4 experiments). Bar 1, control group; bar 2, shRNA-SIRT1 group; bar 3, LV-SIRT1 group. *p<0.05, statistically significant difference compared to the control group.

PQ induces the apoptosis of mouse AECs-II

The proportion of early apoptotic and late apoptotic cells was counted. As shown in Fig. 2, following exposure to increasing concentrations of PQ, the proportion of early apoptotic cells increased; however, when the concentration reached 1000 μM, the percentage of late apoptotic cells increased significantly more than the proportion of early apoptotic cells at the same time. Similarly, in the groups of cells exposed to a PQ concentration of 800 μM for different periods of time, the proportion of apoptotic cells also increased in a time-dependent manner.

Figure 2 Paraquat (PQ)-induced apoptosis of mouse type II alveolar epithelial cells (AECs-II). The mouse AECs-II were treated with various concentrations of PQ (0, 200, 400, 800 and 1000 μM; top and middle panels) for 24 h, and also treated with 800 μM PQ for 6, 12, 24 and 48 h (bottom panels). The apoptosis of the cells was detected using a FACSCalibur flow cytometer. The 4 quadrants indicate the following: left upper quadrant, mechanically broken cells; left lower quadrant, surviving cells; upper right quadrant, late apoptotic cells; lower right quadrant, early apoptotic cells.

Protein expression of SIRT1 and NRF2 in mouse AECs-II following exposure to PQ

To assess the potential roles of SIRT1 and NRF2 in PQ-induced lung injury, the protein levels of SIRT1 and NRF2 were measured by western blot analysis in the mouse AECs-II following exposure to various concentrations of PQ for 24 h (Fig. 3A) and exposure to 800 μM PQ for different periods of time (Fig. 3B). The results revealed that exposure of the cells to low concentations (200 and 400 μM) of PQ upregulated the protein expression of SIRT1 and NRF2. With the increasing concentations (800 and 1000 μM) of PQ, the protein expression of SIRT1 and NRF2 gradually decreased. Furthermore, during the short periods of exposure to PQ, the protein expression of SIRT1 and NRF2 was significantly elevated and peaked at 12 h. As the duration of exposure to PQ was extended, the protein expression of SIRT1 and NRF2 gradually decreased.

Figure 3 Protein expression of silent information regulator 2-related enzyme 1 (SIRT1), nuclear factor E2-related factor 2 (NRF2) in mouse type II alveolar epithelial cells (AECs-II) following exposure to paraquat (PQ). Mouse AECs-II were treated with (A) 200, 400, 800 and 1000 μM PQ for 24 h and (B) also treated with 800 μM PQ for 6, 12, 24 and 48 h. The protein expression of SIRT1 and NRF2 was measured by western blot analysis. The values are expressed as the means ± SD (n=4 experiments). * p<0.05, statistically significant difference when compared with the control group.

Effects of PQ on SOD, CAT and HO-1 activities, as well as on GSH and MDA levels in mouse AECs-II

Following exposure to low concentrations of PQ (200 and 400 μM) for 24 h (Fig. 4A–D), the SOD, CAT and HO-1 activities, as well as the GSH levels significantly increased compared with the control groups. As the PQ concentration increased (800 and 1000 μM), the activities of SOD, CAT and HO-1, as well as the levels of GSH gradually decreased. The levels of MDA (Fig 4E) in the cells increased in a PQ concentration-dependent manner.

Figure 4 Effect of paraquat (PQ) on superoxide dismutase (SOD), catalase (CAT) and heme oxygenase-1 (HO-1) activities, as well as on glutathione (GSH) and malondialdehyde (MDA) levels in mouse type II alveolar epithelial cells (AECs-II). The mouse AECs-II were treated with (A–E) 200, 400, 800 and 1000 μM PQ for 24 h and (F–J) also treated with 800 μM PQ for 6, 12, 24 and 48 h. The activities of SOD and CAT, and the levels of GSH, MDA and HO-1 were respectively measured using the corresponding detection kits. The values are expressed as the means ± SD (n=4 experiments). *p<0.05, statistically significant difference when compared with the control group.

Following a 12-h challenge with 800 μM PQ (Fig. 4F–H), the GSH levels and CAT activity significantly increased compared with the untreated control cells, reaching peak levels. SOD activity reached a peak at 6 h. With the extension of the duration of exposure to PQ, the activities of SOD and CAT, as well as the GSH levels were markedly decreased compared with the control groups. The levels of MDA and HO-1 (Fig. 4I and J) in the cells increased in a time-dependent manner.

Overexpression of SIRT1 inhibits the apoptosis of AECs-II

Following the knockdown or upregulation of SIRT1 expression, the mouse AECs-II were challenged with 800 μM PQ for 24 h. The overexpression of SIRT1 significantly decreased the cell apoptotic rate. On the contrary, the downregulation of SIRT1 enhanced the apoptotic rate of the cells (Fig. 5A–D).

Figure 5 Silent information regulator 2-related enzyme 1 (SIRT1) protein inhibits paraquat (PQ)-induced apoptosis and suppresses oxidative stress in mouse type II alveolar epithelial cells (AECs-II). Transfected mouse AECs-II were exposed to 800 μM PQ for 24 h. (A–D) The apoptosis of the cells was detected using a FACSCalibur flow cytometer. (A) Control group; (B) PQ group; (C) PQ + shRNA-SIRT1 group; (D) PQ + LV-SIRT1 group. (E–I) The activities of superoxide dismutase (SOD), catalase (CAT), heme oxygenase-1 (HO-1), and the levels of glutathione (GSH) and malondialdehyde (MDA) were detected using the corresponding detection kits. The values are presented as the means ± SD (n=4 experiments). Bar 1, control group; bar 2, PQ group; bar 3, PQ + shRNA-SIRT1 group; bar 4, PQ + LV-SIRT1 group. *p<0.05, statistically significant difference when compared with the control group; #p<0.05, statistically significant difference when compared with the PQ group.

SIRT1 protein suppresses PQ-induced oxidative stress in mouse AECs-II

Compared with normal conditions, SOD and CAT activity, as well as the GSH levels were markedly inhibited in the mouse AECs-II following exposure to 800 μM PQ (Fig. 5E–G). The silencing of SIRT1 by shRNA targeting SIRT1 (shRNA-SIRT1) suppressed the activity of SOD and CAT, as well as the GSH levels to an even greater extent compared with the cells epxosed to PQ and not transfected with shRNA, whereas the overexpression of SIRT1 using a SIRT1 overexpression vector (LV-SIRT1) markedly increased the activity/levels of these enzymes (Fig. 5E–G). Conversely, the MDA levels and HO-1 activity (Fig. 5H and I) were notably elevated in the mouse AECs-II following exposure to PQ. The silencing of SIRT1 increased the expression of MDA, whereas the upregulation of SIRT1 had the opssosite effect. However, the overexpression of SIRT1 promoted HO-1 activation and upregulated its expression.

SIRT1 protein expression upregulates NRF2 protein expression

The mouse AECs-II in which SIRT1 was either overexpressed or knocked down were exposed to PQ and harvested at 24 h. As shown in Fig. 6A and B, the overexpression of SIRT1 promoted the expression of NRF2, whereas the knockdown of SIRT1 blocked NRF2 activation. NRF2 expression correlated with the levels of SIRT1.

Figure 6 Silent information regulator 2-related enzyme 1 (SIRT1) protein upregulates the expression and stability of nuclear factor E2-related factor 2 (NRF2) protein by deacetylating NRF2. Mouse type II alveolar epithelial cells (AECs-II) were treated with 800 μM paraquat (PQ) for 24 h after successful transfection. (A and B) The protein expression levels of SIRT1 and NRF2 were then measured by western blot analysis. (E–I) Transfected mouse AECs-II were treated with 100 μg/ml of cycloheximide (CHX) for 0, 6, 12 and 24 h following exposure to PQ. The protein stability of NRF2 was measured by western blot analysis. (E) Control group; (F) PQ group; (G) PQ + shRNA-SIRT1 group; (H) PQ + LV-SIRT1 group. (C and D) Following successful transfection, the NRF2 protein was immunoprecipitated with anti-NRF2 antibody. The acetylated NRF2 protein was detected by western blot analysis using anti-acetyl-lysine antibody. Lane 1, Control group; lane 5, shRNA-SIRT1, group; lane 6, LV-SIRT1 group. The values are presented as the means ± SD (n=4 experiments). *p<0.05, statistically significant difference when compared with the control group; #p<0.05, statistically significant difference when compared with the PQ group. Lane or bar 1, control group; lane or bar 2, PQ group; lane or bar 3, PQ + shRNA-SIRT1 group; lane or bar 4, PQ + LV-SIRT1 group; lane or bar 5, shRNA-SIRT1 group; lane or bar 6, LV-SIRT1 group.

SIRT1 protein enhances the stability of NRF2 protein

The stability of NRF2 protein expression gradually decreased following exposure of the cells to PQ for 6 h. In the control group (Fig. 6E and I), the expression of NRF2 decreased by 24.7 and 42.51% at 12 and 24 h, respectively. In the PQ group (Fig. 6F and I), NRF2 expression decreased by 53.77 and 71.6%, following treatment with CHX for 12 and 24 h, respectively. In the PQ + shRNA-SIRT1 group (Fig. 6G and I), the downregulation of SIRT1 significantly damaged the stability of NRF2, with the decrease in expression reaching 71.7 and 74.8% at 12 and 24 h, respectively. In the PQ + LV-SIRT1 group (Fig. 6H and I), the upregulation of SIRT1 protein expression played a negative role in the degradation of NRF2 protein, with the decline only reaching 41.0 and 47.9% at the corresponding time points.

SIRT1 protein deacetylates NRF2 protein in mouse AECs-II

To determine whether SIRT1 plays a vital role in the acetylation of NRF2 protein, the levels of acetylated NRF2 in the cells were detected. Our data (Fig. 6C and D) revealed that the NRF2 protein acetylation level was markedly upregulated by the depletion of SIRT1, whereas the overexpression of SIRT1 reduced the NRF2 acetylation level.

Discussion

Previous studies have reported that PQ-induced pulmonary toxicity directly results in bronchial toxicity, inflammation and oxidative stress (18,19,20). It has been reported that excessive amounts of ROS-mediated oxidative stress play an important role in the process of PQ-induced pulmonary injury (21,22). PQ is an influential inducer of ROS and may prompt the generation of ROS, such as superoxide anions, as well as hydroxyl and peroxyl radicals (1,23). After cellular uptake, PQ has been found to target the mitochondria and through cyclic reduction-oxidation reactions, causes an increase in intracellular ROS generation, which then leads to the apoptosis of cells (10,24). The findings of the present study revealed that exposure of the cells to high concentrations of PQ induced a significant increase in the MDA content, whereas the activities of SOD and CAT were decreased, which was consistent with the findings of a previous study (25).

In a previous study, NRF2 was considered as an effective target for the antioxidant therapy of PQ poisoning (15). The levels of oxidative stress were assessed by measuring the levels/activity of MDA, SOD, GSH and CAT, which were also associated with its anti-apoptotic properties (26). It has been proven that NRF2 expression maintains the balance of the oxidant-antioxidant system and inhibits inflammation, as well as apoptotic factors, which are associated with an anti-apoptotic effect on cell injury induced by PQ (27). As NRF2 may activate cellular responses through enhanced transcription by antioxidant response element (ARE), this leads to increases in the expression levels of antioxidant enzymes. including CAT, SOD, GSH and glutathione peroxidase (GPx) (15,28). It has been demonstrated that the ability to eliminate electrophiles and free radicals is enhanced by these defensive proteins, which collectively promotes the detoxification of ROS, and increases the capacity of cells to resist apoptosis (12,29). Previous studies have confirmed that the depletion of NRF2 by siRNA down-regulates the expression of SOD and upregulates the levels of MDA and apoptotic factors, including phosphorylated p53, Bax and the active form of caspase-3, which significantly enhances PQ-induced oxidative damage in cells in vitro (18,30). Moreover, NRF2 enhances the inhibitory effects of HO-1 on the intracellular production of ROS (31). Additionally, it has been demonstrated that the overexpression of NRF2 effectively alleviates PQ-induced lung injury and cell apoptosis (32). In the present study, we verified that NRF2 overexpression induced by transfection with LV-SIRT1 played an important protective role by reducing the cell apoptosis induced by PQ. This study provides evidence of the involvement of the NRF2 signaling pathway in the antioxidant effects exerted by SIRT1, thereby improving the endogenous cellular anti-apoptotic system.

In unstressed cells, NRF2 has been found to be sequestered by its inhibitor, Keap1, thereby promoting rapid proteasome-mediated degradation (33). However, in response to oxidative stress, NRF2 dissociates from Keap1, through modifications to the Keap1-NRF2 complex, such as ubiquitination, proteasomal degradation or phosphorylation (34). NRF2 has been found to be regulated by acetylation; the results of a previous study indicated that NRF2 acetylation at lysine residues in the Neh1 DNA-binding domain was responsible for NRF2 transactivation rather than for stability (35). However, a previous study also demonstrated that the downregulation of histone deacetylase (HDAC)2 may cause the impaired functioning of NRF2, which leads to the reduced expression of the antioxidant responsive genes and thus, it was concluded that HDAC2 may regulate NRF2 activity through deacetylation (36). In this study, we found that SIRT1 deacetylated NRF2 in cells, thus increasing its stability, resulting in the enhanced expression of antioxidant genes and decreased sensitivity to oxidative stress.

It is well known that sirtuins are involved in various aspects of biological processes through deacetylation, such as the regulation of gene expression, cellular stress response and DNA repair (37). There is a close association between SIRT1 expression and oxidative stress. Cigarette smoke-mediated oxidative stress has been reported to decrease SIRT1 protein levels and activity in the lungs of rats and human beings (4,38). In the present study, SIRT1 overexpression was associated with a high level of GSH, as well as SOD and CAT activities, the downstream genes of NRF2-anti-ARE, whereas the depletion of SIRT1 markedly increased the activity of MDA and HO-1, which suggested that SIRT1 protein may play an important role in mediating the oxidant-antioxidant balance in PQ-induced pulmonary injury (39) and enhanced cell resistance to oxidative stress. In a previous study of ours (40), resveratrol, an activator of SIRT1, increased the SIRT1 and NRF2 levels, and through the activation of the NRF2-ARE pathway led to the suppression of ROS production.. In that study, we demonstrated that PQ stimulated the compensatory overexpression of SIRT1 and NRF2, whereas exposure to PQ for a longer period of time significantly decreased the expression of SIRT1, as well as NRF2 in the lungs of mice. Additionally, treatment with resveratrol not only upregulated the expression of SIRT1 and NRF2, but also increased the activities of HO-1, SOD and CAT. The depletion of SIRT1 has also been shown to block NRF2-ARE pathway activation and reverse the antioxidative capacity (15). In this study, our results revealed that the upregulation of SIRT1 expression markedly increased the expression of NRF2, whereas the knockdown of SIRT1 had a negative influence on the levels of NRF2 expression. Therefore, we hypothesized that SIRT1 protein would alleviate PQ-induced oxidative stress through the NRF2 pathway. It has previously been confirmed that SIRT1 promotes nuclear accumulation, DNA binding and the transcriptional activities of NRF2 and promotes the expression of the NRF2 downstream genes, HO-1, and SOD, resulting in the reduction of ROS levels in a deacetylase-dependent manner (14). Importantly, SIRT1 is a redox-sensitive deacetylase that is post-translationally modified by oxidants and carbonyl stress (4). We found that the upregulation of SIRT1 caused NRF2 deacetylation, resulting in the increased stability and activity of NRF2, thus causing the suppression of apoptosis and resistance to oxidative stress.

Collectively, our results demonstrated that SIRT1 enhanced and stabilized NRF2 protein expression. We demonstrated that SIRT1 was associated with NRF2 and prevents its degradation possibly through the deacetylation of various residues. As the reduced SIRT1 activity is observed in PQ poisoning due to oxidative stress, this may consequently reduce the activity of NRF2, thus inhibiting an increase in the expression of antioxidant enzymes; this in turn increases oxidative stress, which then further reduces SIRT1 activity; this process is an ongoing vicious circle. SIRT1 overexpression in cells may upregulate Nrf2 expression by increasing Nrf2 deacetylation, resulting in the enhancement of normal antioxidant defences.

Acknowledgments

This study was supported by the State Key Program of Natural Science Foundation of Zhejiang province (no. LZ12H26001), and the Medical and Health Research Program of Zhejiang province (no. 2012ZDA034).

References